SAABOA - Strategy As A Basis Of Action

Defining the long-term aspirational vision of assets, portfolios, and corporations

Vision

Today’s multidisciplinary environment of pharmaceutical development and commercialization is enhanced by clear alignment and communication. You want your team focused and working together towards shared objectives, but reaching consensus can be challenging. Defining and articulating a long-term vision requires courage but offers significant rewards. What are your aspirations, and do they extend beyond development of a single product? What value could they create? SAABOA Vision aligns and engages teams to define a strategic framework of the values they wish to activate and build upon, bringing to life the unique value of an asset, portfolio or corporation.

Addressing uncertainty by identifying the underlying dynamics of change

Environment

As healthcare rapidly evolves, traditional analytics struggle to keep pace. Clinical expert advice is often subjective, while market analytics deliver huge amounts of data without strategic insight or ‘so what?’ SAABOA’s Future Matters services help manage market uncertainty by clearly defining key strategic questions and providing an objective, multi-dimensional understanding of market dynamics and change across competitors, policy, regulators, patients, payers, and providers. While predicting the future is impossible, we can identify and assess the potential impact of alternative future scenarios, enabling businesses to make proactive strategic choices, adapt their products and services, and shape their market environment.

Creating the organizing principle behind an aligned portfolio vision and definition

Portfolio

Commitment to a therapeutic area means more than grouping products into a portfolio. SAABOA’s portfolio approach has two components: Portfolio Vision & Definition (PVD) and Portfolio Alignment (co-positioning). Franchise commitment drives business growth, turning your therapeutic focus into a standalone enterprise. Our PVD approach identifies your enterprise’s core values and differentiates you from competitors. Portfolio Alignment maximizes individual brand value and performance, while maintaining flexibility to ensure the overall portfolio meets commercial goals.

Aligning payer and clinical value into a clearly-defined commercial product strategy

Product

Positioning an asset too early in development risks obsolescence as data and markets change; too late, and you lose influence over the product label, the core constituent of defining value at launch. SAABOA believes that while defining the value of an asset requires focused, aligned execution, an actionable positioning strategy must remain flexible to adapt to new circumstances. Asset Design and Definition is a cross-functional approach used at various lifecycle stages, aligning an asset’s science, payer value, future clinical development, and labeling into a unified, differentiated, robust and adaptable path-to-market approach.

V
VISION
E
ENVIRONMENT
P
PORTFOLIO
P
PRODUCT